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Abstract
The emergence and rapid spread of carbapenemases in Enterobacteriaceae, Pseudomonas and Acinetobacter (EPA) species is becoming a major
public health crisis worldwide, and is responsible for large number of hospital-acquired and nosocomial infections. In this article, we review
the current knowledge on the classiﬁcation, phylogeny and genetic platforms of the main carbapenemases already described in
Gram-negative bacteria.
Keywords: Acinetobacter, carbapenemases, Enterobacteriaceae, multidrug-resistant bacteria, Pseudomonas
Article published online: 28 April 2014
Clin Microbiol Infect 2014; 20: 831–838
Corresponding author: J.-M. Rolain, Aix-Marseille Universite,
URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, 27 Bd Jean
Moulin, 13385 Marseille Cedex 05, France
E-mail: jean-marc.rolain@univ-amu.fr
Introduction
The emergence of resistance to carbapenems in Gram-negative
bacteria, including Enterobacteriaceae, Pseudomonas and Acinet-
obacter (EPA) species, over the last decade has become a major
public health crisis worldwide, because of their rapid spread and
the lack of development of new antimicrobial drugs. Since the
description of a metallo-b-lactamase, IMP-1, in Pseudomonas
aeruginosa [1], a serine carbapenemase, OXA-23, in Acinetobac-
ter baumannii [2], and a serine carbapenemase, KPC-1, in
Klebsiella pneumoniae [3], carbapenemase-encoding genes have
spread worldwide, and are now distributed through the main
Gram-negative multidrug-resistant bacteria, which are respon-
sible for a large number of hospital-acquired and nosocomial
infections. Carbapenemases are enzymes that inhibit almost all
b-lactam antibiotics, including carbapenems, and have now been
reported mainly in Enterobacteriaceae, A. baumannii, and P. aeru-
ginosa [4]. Although carbapenemases were reported to be
species-speciﬁc in the 1990s, the identiﬁcation and spread of
plasmid-encoded carbapenemases has recently changed our
view of the magnitude of the problem in Gram-negative
bacteria, especially the rapid and extensive worldwide
dissemination of carbapenem-resistant bacteria carrying the
KPC-type, VIM-type, NDM-type and OXA-type carbapenemas-
es [5,6]. In this review, we summarize the phylogeny and genetic
platforms of the main carbapenemases already described in
Gram-negative bacteria.
Classiﬁcation of Carbapenemases
Classiﬁcation of carbapenemases can be achieved both func-
tionally and genetically, and is summarized in Fig. 1. Carba-
penemases are divided into two groups according to their
active sites: (i) serine carbapenemases belonging to the class A
penicillinases and class D oxacillinases, which contain a serine
in the active site and can be inactivated by b-lactamase
inhibitors, including clavulanic acid and tazobactam; and (ii)
metallo-b-lactamases belonging to the class B carbapenemases,
which contain one or more zinc atoms at the active site,
allowing them to hydrolyse the bicyclic b-lactam ring. These
enzymes are inhibited by EDTA [5,7–9] (Fig. 1).
Class A carbapenemases
Class A carbapenemases include the IMI/NMC, SME, KPC and
GES enzymes that confer resistance to carbapenems at various
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FIG. 1. Phylogenetic tree of the metallo-carbapenemase and serine carbapenemase genes with their mean percentage GC content, according to
groups and phenotypic properties. The tree was constructed from the amino acid sequences aligned with the free ClustalX software version 2.0 and
MEGA software version 6.06, by use of the neighbour-joining method with the amino acid Poisson correction model with 1000 bootstrap replicates.
Bootstrap values are expressed as percentage of the 1000 replicates, and only those up to 50% are kept and shown at branch points. aOXA genes
described overall in Gram-negative bacteria. bOXA genes described only in Acinetobacter species. The percentage GC values correspond to the
averages of each subgroup. ATM, aztreonam; CLA, clavulanic acid; R, resistant; S, susceptible.
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levels, from reduced susceptibility to full resistance [5]. SME,
NMC and IMI enzymes are usually chromosomally encoded,
whereas KPC and GES enzymes are plasmid-encoded [5]
(Fig. 1). SME enzymes are usually restricted to Serratia
marcescens, whereas IMI and NMC enzymes are sporadically
detected in Enterobacter cloacae [5]. The fact that these latter
three types of enzyme are chromosomally encoded probably
explains why they are rarely reported worldwide. Conversely,
the genes for KPC enzymes are found on transferable
plasmids, and are highly prevalent, mainly in K. pneumoniae,
but have also been detected in other Enterobacteriaceae,
P. aeruginosa, and A. baumannii [4]. The genes for GES enzymes
are found in integrons on transferable plasmids in P. aeruginosa
and K. pneumoniae [5].
Class B carbapenemases
Class B metallo-b-lactamases include the IMP, VIM, GIM, SIM
and NDM enzymes, whose genes are mainly found in transfer-
able plasmids in Enterobacteriaceae, but are also found in
P. aeruginosa and A. baumannii. The IMP-type enzymes, initially
reported in 1991 in an S. marcescens clinical isolate from Japan
[10], have now been reported all over the world in Enterobac-
teriaceae, P. aeruginosa, and A. baumannii [6]. Among the
VIM-type enzymes, which now comprise >30 variants, blaVIM-1
was reported for the ﬁrst time in Verona, Italy, in a P. aeruginosa
clinical isolate recovered in 1997, and was integrated as a gene
cassette located in a class I integron along with an aacA4 gene
responsible for aminoglycoside resistance [11]. This gene was
also reported in an Escherichia coli isolate from Greece in
November 2001 that carried blaVIM-1 along with with aacA7,
dhfrI and aadA located in a class I integron [12]. Since then, both
E. coli and K. pneumoniae with blaVIM-1 have spread in Greece
[13,14], and they have now been reported all over the world
[6]. The VIM-2 variant was ﬁrst reported in a P. aeruginosa
clinical isolate from France, the gene also being integrated as a
gene cassette in a class I integron [15], and is now endemic in
many countries worldwide [6]. NDM enzymes have been
reported recently [16], and the ﬁrst large series of clinical
isolates from Asia and UK were reported in August 2010 [17].
Since this report, NDM-1 has spread worldwide [18], and it is
now one of the most common carbapenemases in all Entero-
bacteriaceae and in A. baumannii [4,6,19].
Class D carbapenemases
Class D metallo-b-lactamases are also known as OXA b-lac-
tamases, for ‘oxacillin-hydrolysing’, and their genes are found
both on plasmids and in the chromosome. Basically, the
OXA-23, OXA-24 and OXA-58 groups are mainly found in
A. baumannii, whereas OXA-48 is increasingly being reported
in K. pneumoniae [5].
Phylogenetic relationships among carbapenemases
As shown in Fig. 1, there is wide diversity and notable
phylogenetic evolution among the carbapenemase-encoding
genes, and several groups and subgroups can be distinguished.
First, three main phylogenetic groups can be identiﬁed: class B
carbapenemases (Fig. 1; Amber class B), which include the
metallo-carbapenemase genes, including IMP genes, SIM genes,
GIM genes, VIM genes, and NDM genes [7]; and classes A and
D (Fig. 1; Amber classes A and D), which include the serine
carbapenemase genes, including GES genes, IMI genes, NMC
genes, SME genes, BIC genes, KPC genes, and OXA genes [7].
Second, several subgroups can be distinguished according to
the mean percentage GC content, which varies from 38.06%
for the subgroup blaOXA
a to 61.5% for the subgroup blaNDM.
Furthermore, as shown in Fig. 2, the percentages of identity of
the most described carbapenemases are sometimes very low
(<10%). These results suggest that these genes do not have a
common evolutionary history, despite the fact that they show
similar enzymatic activity against the same antibiotic class with
more or less the same efﬁcacy. Interestingly, some carbape-
nemase enzymes, such as OXA-23 and OXA-24, have always
been speciﬁcally described in A. baumannii, whereas some
other enzymes, such as KPC enzymes, are most often
described in Enterobacteriaceae, and have also been found in
Pseudomonas and Acinetobacter species [5]. This highlights the
speciﬁc dissemination of some carbapenemase genes among
some species, and interspecies dispersion of these genes in
Gram-negative bacteria. Thus, it is not possible to design
universal molecular tools for the detection of all carbapenem-
ase-encoding genes.
Distribution of Carbapenemase Enzymes in
Gram-negative Bacteria
Within the Enterobacteriaceae, almost all carbapenemase genes
have been described except for the serine carbapenemase
blaOXA
a genes (Fig. 1), which have only been reported in
Acinetobacter species. After the ﬁrst description of a carbape-
nemase in Enterobacteriaceae, speciﬁcally S. marcescens, in 1990
[20], an increase in carbapenemase-producing Enterobacteria-
ceae has been reported during the last 20 years. According to
an evaluation of the number of publications that describe
carbapenemase genes in Enterobacteriaceae, performed by
using the PubMed database with keywords ‘type carbapenem-
ase and Enterobacteriaceae’, KPC genes (with 379 publica-
tions) have been the most reported in Enterobacteriaceae since
the ﬁrst description in 2001 in the USA in K. pneumoniae [3],
and have since been reported worldwide [21]. After KPC
genes, OXA genes (with 149 publications) are in second
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position, and include mainly blaOXA-48, blaOXA-162, and
blaOXA-181 [10–12], followed by NDM genes (with 131
publications), described for the ﬁrst time in 2009 [16], VIM
genes (with 119 publications), mostly described in P. aerugin-
osa, IMP genes (with 80 publications), SME genes (with 27
publications), and the other genes, with <20 publications.
In the serine carbapenemase group, KPC enzymes are by far
most well described and widespread in Enterobacteriaceae,
especially in nosocomial K. pneumoniae isolates, but are also
well described in E. coli (mainly in Israel) and in other
Enterobacteriaceae, including Citrobacter, Enterobacter, Serratia,
and Proteus [5,20,22]. The worldwide spread of KPC genes in
Enterobacteriaceae has been shown to be associated with a
genetic mobile element (transposon Tn4401) [23]. As shown
in Fig. 1, the other serine carbapenemases, including GES, SME,
IMI, NMC and BIC enzymes, share with KPC enzymes a
common ancestor, as previously reported [24]. Among them,
SME enzymes, which were discovered in S. marcescens in 1990,
have been exclusively found in this species [5,24], whereas
NMC-A and IMI enzymes, which differ by fewer than ten amino
acid substitutions, have been mainly described in Enterobacter
cloacae and E. coli [5,24]. GES enzymes now comprise 24
sequence types; however, only GES-2, GES-4, GES-5, GES-6,
GES-14, GES-18 have been reported to show enzymatic
activity against carbapenems [5,25]. These GES enzymes have
been mostly described in P. aeruginosa [5,24], but are also
found in Enterobacteriaceae, e.g. GES-5 in K. pneumoniae, E. coli,
and Enterobacter cloacae [5,26,27]. The OXA enzymes, with
more than 389 sequence types having been described (http://
www.lahey.org/Studies/), are the most variable among the b-
lactamase and serine carbapenemase enzymes; however, only
some of them are reported to be carbapenem-hydrolysing
enzymes, including mainly OXA-23, OXA-24, OXA-58, and
some close orthologs of these [28], which have only been
reported in Acinetobacter species, and OXA-48, OXA-162, and
OXA-181, which have also been described in Enterobacteria-
ceae. The blaOXA-48 gene, discovered for the ﬁrst time in 2004
in a K. pneumoniae strain isolated in Turkey [29], is the most
widespread in Enterobacteriaceae. Indeed, OXA-48 has been
described in different Enterobacteriaceae, including E. coli,
S. marcescens, Enterobacter cloacae, Klebsiella oxytoca, Providencia
rettgeri, and Citrobacter freundii [30]. This enzyme hydrolyses
carbapenems at a low level, but, in combination with a
membrane impermeability mechanism, can induce high-level
resistance to carbapenems [30]. Some OXA-48 variants,
including OXA-181, OXA-204, and OXA-232, have been also
reported in Enterobacteriaceae, and have shown similar activity
against carbapenems [30]. Interestingly, the OXA-162 variant,
which differs from OXA-48 by a single amino acid substitution,
has lower activity against carbapenems than OXA-48, but is
able to hydrolyse penicillins, ceftazidime, and cefotaxime,
whereas OXA-48 is not [31].
FIG. 2. Pairwise comparison of protein sequence identities of the most well-described carbapenemases. Protein sequences are aligned, and the
numbers of identical amino acids and percentages of sequence identity are shown. Values above the diagonal line refer to the sequence identity
percentages, and values below the diagonal line refer to the number of identical amino acid. The analysis is done using CLC genomics software.
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As reported previously, metallo-carbapenemase enzymes,
including IMP, GIM,VIM, and GIM, have been historically by far
most widespread in P. aeruginosa and Acinetobacter species;
however, recently, these enzymes have emerged signiﬁcantly in
Enterobacteriaceae [28]. Indeed, one of the main concerns
regarding carbapenem resistance in the last few years has been
the emergence of metallo-carbapenemase genes in Enterobac-
teriaceae [32]. The ﬁrst metallo-carbapenemase enzyme
described in Enterobacteriaceae was IMP-1 in S. marcescens in
1994 [10]. Therefore, these enzymes have now been described
in almost all Enterobacteriaceae, including E. coli, C. freundii,
Citrobacter koseri, K. pneumoniae, K. oxytoca, Enterobacter aer-
ogenes, Enetrobacter cloacae, Proteus mirabilis, Providencia rettgeri,
Morganella morganii, and Shigella ﬂexneri [5]. Interestingly, for
unknown reasons, the particular metallo-carbapenemase
VIM-2, discovered in 2000 in P. aeruginosa [15], has emerged
and been reported to be widespread in Gram-negative bacteria
worldwide in the last 10 years [7]. The VIM enzymes, of which
there are approximately 33 variants, have been widely
described in P. aeruginosa, and have been found to a lesser
extent in Enterobacteriaceae, despite their description in
K. pneumoniae and Enterobacter cloacae [6,33]. GIM-1 has been
recently reported in Enterobacter cloacae, K. oxytoca, S. mar-
cescens, E. coli, and C. freundii [34], whereas the metallo-carb-
apenemase SIM-1 has so far not been described in
Enterobacteriaceae. The last metallo-carbapenemase enzyme
discovered was NDM-1 (New Delhi metallo-b-lactamase-1),
which was reported for the ﬁrst time in 2009 [16], and has
since been reported in enterobacterial isolates in >280
publications (PubMed). This enzyme, with its ten variants, has
spread worldwide, and now represents a major concern
regarding carbapenem resistance in Gram-negative bacteria
[4,6,18]. This enzyme has been identiﬁed in almost all
enterobacterial isolates, including K. pneumoniae, K. oxytoca,
E. coli, Proteus mirabilis, C. freundii, Enetrobacter cloacae, and
M. morganii [35].
Genetic Platforms of Carbapenemase Genes
in EPA Species
The EPA species are today well recognized to constitute the
most common source of both community-acquired and
hospital-acquired infections. These bacteria can spread easily
and rapidly between humans, via the hands, materials used (in
hospital settings), contaminated foods, or water, and can
therefore exchange genetic material by lateral gene transfer,
mainly mediated by plasmids and transposons [36]. However,
these carbapenemases can be divided into those that are
usually chromosomally encoded and those that are encoded by
mobile genetic elements, including transposons, integrons, and
plasmids [5]. Indeed, the serine carbapenemase enzymes,
including SME, NMC-A, and IMI, which have been less well
described than the other carbapenemases in EPA species, are
chromosomally encoded in some species, including S. marces-
cens and Enterobacter cloacae. These enzymes are extremely
rarely associated with mobile genetic elements, and perhaps
this has contributed to their rarity in EPA species [5], despite
the report of IMI-2 being encoded by a plasmid in Enterobacter
cloacae [37]. In contrast to the enzymes cited above, the KPC
and GES enzymes are well described as being mostly encoded
by transferable plasmids [5]. Indeed, as reported, the ﬁrst KPC
gene was discovered in a large plasmid that encodes the KPC-1
carbapenemase enzyme. Shortly after this, a variant of KPC-1,
i.e. KPC-2, which differs by a single amino acid was reported,
and now represents the most common KPC enzyme world-
wide in Gram-negative bacteria [21]. Interestingly, a single
K. pneumoniae clone, ST-258, harbouring KPC-2 has been
extensively reported worldwide, suggesting wide spread of
blaKPC-2 [21]. However, it has recently been reported that
KPC-2 is mainly associated with a single mobile genetic element,
transposon Tn4401, that is capable of a high frequency of
transposition (Fig. 3a) [22]. In addition, the transposon Tn4401,
which is identical to those identiﬁed in K. pneumoniae, has been
recently described in a P. aeruginosa plasmid, pCOL-1 (accession
number: KC609323), suggesting the possibility of this transpo-
son being transferred among EPA species.
In contrast to the KPC genes, the OXA carbapenemase
genes have been reported to be associated with both bacterial
chromosomes and plasmids [28]. As shown in Fig. 3b, the
most well described OXA gene in A. baumannii, blaOXA-23, is
generally located on transposon Tn2006, which is almost
always bracketed on both sides by the insertion sequence
ISAba1 [38]. The transposon Tn2006 reported in transferable
plasmids is also often identiﬁed in the bacterial chromosome of
A. baumannii, inserted in the hot spot of the integration comM
gene [39]. As reported in multidrug-resistant A. baumannii, this
comM gene is a hot spot for the integration of genomic islands
of various sizes carrying antimicrobial resistant determinants,
including those responsible for antibiotic, antiseptic and heavy
metal resistance [39]. Like blaOXA-23, which is associated with
ISAba1 (Fig. 3b), blaOXA-58 is often bracketed by two copies of
ISAba3, forming a composite transposon, whereas blaOXA-48,
discovered in a K. pneumoniae plasmid, is associated with
IS1999, located upstream of the transposon Tn1999 [28].
Concerning the metallo-carbapenemase genes, as described
for the ﬁrst acquired metallo-b-lactamase identiﬁed in Pseudo-
monas species, IMP-1 [10], IPM and VIM genes are mainly found
in a class I integron, characterized by an integrase intlI gene
associated with a transposase tnpA located upstream of the
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integron (Fig. 3c). As shown in Fig. 3c, these metallo-carba-
penemase genes are often associated on this class I integron
with genes that encode aminoglycoside resistance (aacA4,
aadA1, and/or aadB), class D b-lactamases (OXA genes),
antiseptic resistance (qacΔG), or chloramphenicol resistance
(catB) [40]. The class I integron has been reported to belong
to the mobile integron elements, which are divided into ﬁve
groups and are always plasmid-mediated; however, some large
integrons, classiﬁed as superintegrons, have been detected in
the chromosome [41]. In addition to the important role of
class I integrons in the dissemination of IMP and VIM genes,
these mobile genetic elements are also widely associated with
the wide spread of antibiotic resistance genes in Enterobacte-
riaceae [41].
The blaNDM-1 gene, the latest metallo-carbapenemase gene
to be found, has now disseminated intercontinentally [18]. In
the study describing the discovery of blaNDM-1 [16], it was
found in a plasmid on a 4.3-kb region linked to the 4.8-kb
complex class I integron. Interestingly, it has been reported
that blaNDM-1 can be associated with different types of
insertion sequence, and this characteristic of blaNDM-1 and
the other metallo-b-lactamase genes partly accounts for their
different propensities to disseminate [6]. Indeed, as shown in
Fig. 3d, in A. baumannii, blaNDM-1 is often bracketed by two
(a)
(b)
(c)
(d)
FIG. 3. Genetic platforms of the most reported carbapenemases in Enterobacteriaceae, Pseudomonas and Acinetobacter species. (a) Class I integron:
mobile genetic element harbouring the metallo-b-lactamase-encoding gene blaVIM-2 from Pseudomomas aeruginosa; ISPa, transposase; intL1, integrase;
blaOXA-2, oxacillinase; aacA4, aminoglycoside-6
0-N-acetyltransferase; aadB, aminoglycoside-modifying enzyme; qaΔG, quaternary ammonium
resistance protein; ISPa (tniC), invertase. (b) Transposon Tn4401a: mobile genetic element from Klebsiella pneumoniae harbouring the class A
carbapenemase-encoding gene blaKPC-2; IRL, inverted repeat left; tnpR, resolvase; tnpA, transposase; ISKpn7, insertion sequence; istA, transposase A;
istB, transposase B; ISKpn6, insertion sequence; IRR, inverted repeat right. (c) Transposon Tn2006: mobile genetic element from Acinetobacter
baumannii harbouring the class D serine carbapenemase-encoding gene blaKPC-23; ISba1, insertion sequence; tnpB, transposase subunit; tnpA,
transposase 1; orfX, hypothetical protein; atpase, AAA ATPase superfamily; tnpA, transposase 1; tnpB, transposase subunit. (d) Transposon Tn125
from A. baumannii harbouring the metallo-carbapenemase-encoding gene blaNDM-1; ISAba125, transposase; bleMBL, bleomycine resistance protein; iso,
similar to delta-phosphoribosylanthranilate isomerase; tat, twin-arginine translocation pathway signal sequence; dvt, divalent cation tolerance protein;
groES, chaperonin protein GroES; groEL, chaperonin protein GroEL; ISCR21, transposase; pac, similar to delta-PAC; truncated phospholipid
acetyltransferase. Conserved genes in these mobile elements are boxed and highlighted.
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copies of the insertion sequence ISAba125, located on the
transposon Tn125 [42]. This transposon Tn125 carrying
blaNDM-1 has also been described in the A. baumannii chromo-
some, supporting the ability of this gene to move between
both bacterial DNA molecules [43]. In Enterobacteriaceae,
blaNDM-1 is also associated with complete or truncated
ISAba125, but is mainly located upstream [42]. Interestingly,
bleMBL, a bleomycin resistance gene, is always coupled with
blaNDM-1, which regulates the RecA-dependent mutation rate,
and therefore plays a role in the stabilization of blaNDM-1-po-
sitive isolates [42]. The same genetic structure of blaNDM-1 as
characterized in Enterobacteriaceae has been in identiﬁed in
P. aeruginosa, where it is located in the variable region of a new
complex class 1 integron bearing the insertion sequence ISCR1
and localized in the bacterial chromosome [44].
Conclusions
Although relatively rare 20 years ago, carbapenemase-produc-
ing bacteria currently constitute a dramatic problem world-
wide, because most of the carbapenemase-encoding genes are
located on transferable genetic elements that are most often
associated with other antibiotic resistance genes, leading to
their rapid transfer and to the spread of uncontrollable
superbugs [45]. Moreover, new antibiotic resistance genes may
emerge from different sources, as recently exempliﬁed with
NDM-1, and their diffusion is unpredictable in a complex
bacterial community [45]. The problem is ampliﬁed by the
absence of development of new antibiotic compounds, and has
led to renewed interest in old antibiotics, such as colistin [46].
Unfortunately, the current increase in the use of colistin as the
last-resort treatment in these situations has led to the
emergence of resistance to colistin in these bacteria [46–51],
which we believe will be the next major public health challenge
in the context of antibiotic resistance in the coming years.
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